Status:
COMPLETED
Acetylsalicylic Acid and Type 2 Diabetes Mellitus
Lead Sponsor:
Centro Universitario de Ciencias de la Salud, Mexico
Conditions:
Diabetes Mellitus, Type 2
Antioxidant Enzyme System
Eligibility:
All Genders
35-50 years
Phase:
PHASE3
Brief Summary
OBJETIVE To assess the effect of acetylsalicylic acid on antioxidant enzymatic system in patients with type 2 diabetes
Detailed Description
A randomized, double blind placebo controlled clinical trial was carried out in 21 adult patients with type 2 diabetes. Acetylsalicylic acid 300mg/d was administered orally for 3 months to study group...
Eligibility Criteria
Inclusion
- Type 2 Diabetes
- BMI 25.0 - 35.0 kg/m2
- HbA1c between 6.5 - 9%.
- Written informed consent
- Same residential area and socioeconomic status.
Exclusion
- Sedentary or heavy physical activity.
- Nonsmokers.
- Body weight was stable for al last 3 months before the study.
- Personal history of hepatic, renal, gastric or coronary artery disease.
- Hypersensibility to acetylsalicylic acid.
Key Trial Info
Start Date :
December 2 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 2 2016
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03341117
Start Date
December 2 2014
End Date
December 2 2016
Last Update
November 14 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.